Sukhatme Mayukh sold ROIV
August 18, 2026 · Form 4 insider transaction
Sukhatme Mayukh sold 136,942 shares of Roivant Sciences Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
136,942
Price
$0.00
Total value
N/A
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 18, 2026
Shares owned after13,559,537
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of stock options to purchase Common Shares that is fully vested.